
Italia Pharmaceuticals Private Limited
About Italia Pharmaceuticals Private Limited
Data last updated:
Italia Pharmaceuticals Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 May 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24232MP1996PTC010830. Its GSTIN is 23AAACJ4095R1Z3 (Madhya Pradesh). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹2.5 Cr and a paid-up capital of ₹39.5 Lakh. It is led by directors Ashish Sharma and Ajay Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 57 Sector E Industrial Area Sanwer Road, Indore, Madhya Pradesh, India – 452001.
As per the financials filed for FY 2024, the company reported a revenue of ₹84.26 Lakh, a growth of 102% compared to the previous year. For the same year it recorded a net profit of ₹4.51 Lakh (net margin 5.4%) and EBITDA of ₹4.72 Lakh (EBITDA margin 5.6%). Revenue has declined at a compounded annual rate (CAGR) of 29% over three years and 23% over five years.
As per MCA filings, the company has open charges of ₹5.75 Cr and satisfied charges of ₹40 Lakh on record. Court records list 2 cases involving the company, including 2 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Italia Pharmaceuticals Private Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No. 57 Sector E Industrial Area Sanwer Road, Indore, Madhya Pradesh, India – 452001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Italia Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Italia Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Italia Pharmaceuticals Private Limited, buy the company report.
Financials of Italia Pharmaceuticals Private Limited
FY 2025 filings availableItalia Pharmaceuticals Private Limited reported revenue of ₹84.26 Lakh (up 102% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 102% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 23%. EBITDA rose 112% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.72 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.51 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.6% | ||||
| Net Profit Margin | 5.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Italia Pharmaceuticals Private Limited, buy the company report.
Board of directors of Italia Pharmaceuticals Private Limited
Italia Pharmaceuticals has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashish Sharma | Director | 28 May 2024 | 2 Years 5 Months | Current |
| Ajay Sharma | Director | 28 May 2024 | 2 Years 5 Months | Current |
Peer comparison
Italia Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kruger Nutra Med Private Limited | ₹84.38 Lakh (FY 2025) | 2.0% | New Delhi, Delhi, India | |||
| Sigma Solvents and Pharmaceuticals Limited | ₹84.35 Lakh (FY 2025) | -29.0% | Mehsana, Gujarat, India | |||
| Italia Pharmaceuticals Private Limitedthis company | ₹84.26 Lakh (FY 2024) | ₹4.51 Lakh | 5.4% | 102.0% | Indore, Madhya Pradesh, India | |
| Canaan Lifescience Pharmaceuticals Limited | ₹84.23 Lakh (FY 2025) | 20.0% | New Delhi, Delhi, India |
To see the full peer comparison of Italia Pharmaceuticals Private Limited, buy the company report.
Auditor
Italia Pharmaceuticals Private Limited is audited by RPLANS AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RPLANS AND ASSOCIATES | FY 2023 | 416396 |
Shareholding
The shareholding of Italia Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Italia Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Feb 2023 | 100700039 | State Bank of India | ₹5 Cr | Open | |
| 13 Oct 2014 | 10526685 | Punjab National Bank | ₹50 Lakh | Open | |
| 08 Mar 1999 | 90201770 | M.P. Financial Corporation | ₹25 Lakh | Open | |
| 02 Aug 2005 | 90204357 | Small Industries Development Bank of India | ₹40 Lakh | Satisfied |
To see the full charge records of Italia Pharmaceuticals Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
Italia Pharmaceuticals Private Limited has 2 court cases on record: 2 filed against it. 1 case is pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Lucknow, Uttar Pradesh | Criminal case | Filed against the company by State of Up | Pending |
| District court, Rangareddy, Telangana | Criminal complaint | Filed against the company by an individual | Disposed |
To see the full case history of Italia Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Italia Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Italia Pharmaceuticals has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAACJ4095R1Z3 | Madhya Pradesh | Active | 01 Jul 2017 |
| 09AAACJ4095R1ZT | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Italia Pharmaceuticals Private Limited, buy the company report.
Recent activity
Italia Pharmaceuticals Private Limited has 7 board changes on record since 2014: 2 appointments and 5 cessations. The latest: Ajay Sharma was appointed as Director on 28 May 2024.
4 earlier events are in the company report.
Frequently asked questions
Italia Pharmaceuticals is an active private limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 May 1996 (30+ years old) and is registered under CIN U24232MP1996PTC010830.
Italia Pharmaceuticals has 2 current directors:
- Ashish Sharma - Director
- Ajay Sharma - Director
The latest financial statements of Italia Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Italia Pharmaceuticals is 23AAACJ4095R1Z3, registered in Madhya Pradesh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 09AAACJ4095R1ZT (Uttar Pradesh).
The CIN (Corporate Identification Number) of Italia Pharmaceuticals is U24232MP1996PTC010830. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Italia Pharmaceuticals has 2 court cases on record: 2 filed against it. 1 is pending.
Italia Pharmaceuticals was incorporated on 15 May 1996, making it 30+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Italia Pharmaceuticals by revenue are Kruger Nutra Med Private Limited, Sigma Solvents and Pharmaceuticals Limited, Canaan Lifescience Pharmaceuticals Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ajay Sharma was appointed as Director on 28 May 2024. Ashish Sharma was appointed as Director on 28 May 2024. Mukesh Mehta ceased to be Director on 28 May 2024. Italia Pharmaceuticals has 7 board changes on record in total.
The registered office of Italia Pharmaceuticals is at Plot No. 57 Sector E Industrial Area Sanwer Road, Indore, Madhya Pradesh, India – 452001.
Italia Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

